Literature DB >> 20553053

WHO's international drug monitoring--the formative years, 1968-1975: preparatory, pilot and early operational phases.

Jan Venulet1, Margaretha Helling-Borda.   

Abstract

Mesh：

Year:  2010        PMID： 20553053     DOI： 10.2165/11532410-000000000-00000

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  5 in total

1.  The electromyographic changes by antibiotics. A preliminary study.

Authors:  Y Herishanu; I Taustein
Journal:  Confin Neurol       Date:  1971

2.  Clinical trial of erythromycin stearate suspension.

Authors:  A C McLeay; J Beveridge
Journal:  Med J Aust       Date:  1971-04-10       Impact factor: 7.738

3.  Experimental bases for the different hepatotoxicity of erythromycin preparations in man.

Authors:  C A Dujovne; D Shoeman; J Bianchine; L Lasagna
Journal:  J Lab Clin Med       Date:  1972-05

4.  Perfusion of the isolated rat liver with erythromycin estolate and other derivatives.

Authors:  J Kendler; S Anuras; O Laborda; H J Zimmerman
Journal:  Proc Soc Exp Biol Med       Date:  1972-04

5.  [Pharmacology of a new potent analgesic].

Authors:  M Herrmann; W Steinbrecher; W Heldt
Journal:  Arzneimittelforschung       Date:  1970-08
  5 in total
  8 in total

1.  Perception on adverse drug reaction reporting by physicians working in southern romania.

Authors:  Marian Sorin Paveliu; Simona Bengea-Luculescu; Mihai Toma; Silvia Fraga Paveliu
Journal:  Maedica (Bucur)       Date:  2013-03

Review 2.  Specific features of medicines safety and pharmacovigilance in Africa.

Authors:  Ambrose O Isah; Shanthi N Pal; Sten Olsson; Alexander Dodoo; Rachida Soulayami Bencheikh
Journal:  Ther Adv Drug Saf       Date:  2012-02

3.  Artificial intelligence in pharmacovigilance: Practical utility.

Authors:  Kotni Murali; Sukhmeet Kaur; Ajay Prakash; Bikash Medhi
Journal:  Indian J Pharmacol       Date:  2020-01-16       Impact factor: 1.200

4.  WHODrug: A Global, Validated and Updated Dictionary for Medicinal Information.

Authors:  Olof Lagerlund; Sara Strese; Malin Fladvad; Marie Lindquist
Journal:  Ther Innov Regul Sci       Date:  2020-02-20       Impact factor: 1.778

Review 5.  Past, present, and future of pharmacovigilance in Korea.

Authors:  Dong Yoon Kang; Kyung-Min Ahn; Hye-Ryun Kang; Sang-Heon Cho
Journal:  Asia Pac Allergy       Date:  2017-07-19

6.  Organizational capacities of national pharmacovigilance centres in Africa: assessment of resource elements associated with successful and unsuccessful pharmacovigilance experiences.

Authors:  H Hilda Ampadu; Jarno Hoekman; Daniel Arhinful; Marilyn Amoama-Dapaah; Hubert G M Leufkens; Alex N O Dodoo
Journal:  Global Health       Date:  2018-11-16       Impact factor: 4.185

7.  Electronic Reporting Systems in Pharmacovigilance: The Implementation of VigiFlow in Brazil.

Authors:  Marcelo Vogler; Heloísa Ricci Conesa; Karla de Araújo Ferreira; Flávia Moreira Cruz; Fernanda Simioni Gasparotto; Karen Fleck; Fernanda Maciel Rebelo; Bianca Kollross; Yannie Silveira Gonçalves
Journal:  Pharmaceut Med       Date:  2020-10

8.  Inconsistent Country-Wide Reporting of Adverse Drug Reactions to Antimicrobials in Sierra Leone (2017-2021): A Wake-Up Call to Improve Reporting.

Authors:  Fawzi Thomas; Onome T Abiri; James P Komeh; Thomas A Conteh; Abdulai Jawo Bah; Joseph Sam Kanu; Robert Terry; Arpine Abrahamyan; Pruthu Thekkur; Rony Zachariah
Journal:  Int J Environ Res Public Health       Date:  2022-03-10       Impact factor: 3.390
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.